DiA Imaging Analysis

Company Overview

Snapshot

Founded in October 2009 by Arnon Toussia Cohen, Noah Liel - Cohen, Hila Goldman Aslan, Hugo Guterman, and Michal Yaacobi, DiA Imaging Analysis operated with 11–50 employees. The company raised a total of $22.46 million across 6 funding rounds from 14 investors. In May 2023, DiA Imaging Analysis was acquired by Philips.

Business overview

DiA Imaging Analysis provides AI-powered ultrasound analysis software designed to address challenges in capturing and analyzing ultrasound images. The company's technology leverages advanced pattern recognition, deep learning, and machine learning algorithms to mimic human visual detection of image borders and motion. Its flagship product, LVivo Seamless, is an AI-based software solution that preselects and analyzes optimal apical cardiac ultrasound views, generating measurements for Strain, EF, and Right Ventricle Size and Function. This solution aims to reduce variability in cardiac ultrasound image analysis. DiA Imaging Analysis operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare, Medical Decision Support, and Digital Medical Diagnostics, serving hospitals and healthcare providers globally.

Strategic signal

In May 2023, DiA Imaging Analysis was acquired by Philips, a significant strategic move that integrates DiA's AI-driven ultrasound analysis capabilities into a major multinational healthcare technology company. This acquisition validates DiA's technology and market position, signaling a potential acceleration in the adoption and integration of AI-powered diagnostic tools within the broader medical imaging industry. For investors, this demonstrates a successful exit and highlights the increasing value placed on AI solutions that enhance diagnostic accuracy and efficiency in healthcare.

Company Intelligence Q&A

What was a significant recent corporate development for DiA Imaging Analysis?

In May 2023, DiA Imaging Analysis was acquired by Philips, integrating its AI-driven ultrasound analysis technology into Philips' healthcare portfolio.

Which investors participated in DiA Imaging Analysis's August 2021 funding round?

In August 2021, DiA Imaging Analysis received funding from Connecticut Innovations and ICON Community Fund.

When did DiA Imaging Analysis secure FDA clearance for its cardiac ultrasound AI auto views selection?

DiA Imaging Analysis was granted FDA clearance for its cardiac ultrasound AI auto views selection in October 2020.

What was the nature of DiA Imaging Analysis's partnership with GE Healthcare?

In November 2017, DiA Imaging Analysis partnered with GE Healthcare to make its AI-powered LVivo EF cardiac tool available for the GE Healthcare Vscan Extend handheld mobile ultrasound.

Did DiA Imaging Analysis receive any grants?

In May 2020, DiA Imaging Analysis received a grant from the Israel Innovation Authority to accelerate global access to its AI ultrasound solutions in the fight against COVID-19.